Pulmonary alveolar proteinosisDefinition: Pulmonary alveolar proteinosis is a disease in which a phospholipid (a compound widely distributed in living cells) accumulates within spaces in the lungs where oxygen and carbon dioxide are exchanged.
Alternative Names: Alveolar proteinosis
Causes, incidence, and risk factors: In some cases, the cause of pulmonary alveolar proteinosis is unknown. In others, it is associated with infection or immune deficiency. This rare disorder generally affects people 30 - 50 years old and is seen in men more often than in women.
Symptoms: There may be no symptoms.
Signs and tests: The health care provider may hear crackles in the lungs. Often, the physical examination is normal.
Treatment: Treatment consists of periodic whole-lung lavage, a washing out of the phospholipids from the lung, performed by specially trained physicians. Lung transplantation has been performed for this disease as well.
Expectations (prognosis): Spontaneous remission occurs in some, while progressive respiratory failure develops in others.
Calling your health care provider: Call your health care provider if symptoms develop. Progressive worsening of shortness of breath indicates that an urgent or emergency condition may be developing.
|